A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers

• Status: Completed
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

This is a open label, single center, single oral dose, study of PRT054021, in healthy subjects.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Portola Pharmaceuticals
• Treatments: Betrixaban

Criteria

Inclusion Criteria:

• Healthy adult men ages of 19 and 65 years old, inclusive

• BMI of 18-35 kg/m2

Exclusion Criteria:

• Clinically significant comorbid disease

• History of substance abuse